To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers

Phase 1 Completed 44 enrolled JW Pharmaceutical

RandomizedSequentialOpen-labelOther

Summary

1. To evaluate the pharmacokinetic and pharmacodynamics characteristics after administration of Reference Drug or Test Drug in healthy volunteers under fasting conditions 2. To evaluate the safety and drug tolerance after administration of Reference Drug or Test Drug in healthy volunteers under fasting conditions

Timeline

Start: 2023-03-10
Primary completion: 2023-06-09
Completion: 2023-06-26

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	C2206	Unknown	—	Oral
Subject	JW0302	Unknown	—	Oral

Indications

No indication recorded.